GlaxoSmithKline Biopharmaceutical Composition Patent Application EP3630824A1
Summary
The EPO Patent Bulletin published GlaxoSmithKline Intellectual Property Development Limited's patent application EP3630824A1 for biopharmaceutical compositions and related methods. The application covers immunological disorders (A61K 39/00, A61K 39/395, C07K 16/24), respiratory conditions (A61P 11/00, A61P 11/06), and dermatological applications (A61P 17/00). The application designates 33 European and international states including all EU member states, CH, TR, NO, and others.
What changed
The EPO Patent Bulletin published application EP3630824A1 filed by GlaxoSmithKline for biopharmaceutical compositions and methods. The application claims compositions for treating immunological disorders, respiratory conditions (asthma, COPD), and skin disorders using antibody-based therapies (C07K 16/24). The international patent classification includes A61K 39/00, A61P 11/00, A61P 17/00.\n\nPharmaceutical companies and biotech firms developing biological therapies should review the published claims for potential freedom-to-operate implications or licensing opportunities. The application has been published but not yet granted; interested parties may monitor EPO register for search reports and subsequent examination proceedings.
What to do next
- Monitor EPO register for further proceedings on application EP3630824A1
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
BIOPHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
Publication EP3630824A1 Kind: A1 Apr 08, 2026
Applicants
GlaxoSmithKline Intellectual Property Development
Limited
Inventors
GRANT, Steven, AKINSEYE, Chika, BHINDER, Tejinder, HOOK, Laura, LEWIS, Alan Peter, ORECCHIA, Martin
IPC Classifications
A61K 39/00 20060101AFI20251017BHEP A61P 11/00 20060101ALI20251017BHEP A61P 17/00 20060101ALI20251017BHEP A61P 11/06 20060101ALI20251017BHEP A61K 39/395 20060101ALI20251017BHEP C07K 16/24 20060101ALI20251017BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.